Recent Articles

• Goodman Real Estate Expands Portfolio with Luxury Acquisition
• Eilean Therapeutics Unveils Innovative Pan-EGFR Inhibitor
• STARZ Set to Announce Third Quarter Earnings and Call
• Clorox Set to Share First-Quarter Results on November 3
• Siemens and Envalior Team Up for Eco-Friendly Electrical Innovations
• International Paper Announces New Quarterly Dividend Plan
• DHT Holdings Responds to Recent Shipping Fee Announcement
• Leadership Changes at La-Z-Boy to Drive Future Innovations
• Par Pacific Prepares for Q3 2025 Earnings and Call Update
• DHT Holdings, Inc. Welcomes Svein Moxnes Harfjeld to Its Board
• Unlocking the Potential of Teledyne Technologies Investment
• Polaris Divests Indian Motorcycle to Carolwood for Growth
• Mullins McLeod Leads with Strong Fundraising Momentum in SC
• Weekly Share Trading Update for Banijay Group Holdings
• Zentalis Pharmaceuticals Highlights Azenosertib at Major Cancer Conference
• NexusTek Achieves 2025 Triple Crown for Outstanding Performance
• PHH Mortgage Unveils Innovative FlexIQ Non-QM Product Suite
• iMDx Targets Transplant Market with New VP Marketing Appointment
• Par Pacific Holdings Prepares for Upcoming Earnings Call
• SM Energy Announces Upcoming Earnings Call and Q3 Results Release
• FTAI Aviation and Finnair Forge Partnership for Engine Solutions
• Select Water Solutions Prepares for Upcoming Earnings Call
• Explore Pyxis Oncology's Innovative Approach to Cancer Treatment
• Talos Energy's Upcoming Earnings Call and Q3 Results Release
• DHT Holdings Welcomes Svein Moxnes Harfjeld to Board
• Casella Waste Systems Plans Conference Call for Quarter Results
• NMI Holdings Prepares for Upcoming Financial Results Announcement
• Boundless Bio to Present Breakthrough Cancer Research at AACR
• MAIA Biotechnology Secures $736,600 in New Funding for Trials
• LifeVantage to Showcase Innovations at Upcoming LD Micro Event
• PMV Pharmaceuticals Showcases Rezatapopt Insights at Conference
• Spyre Therapeutics Unveils Exciting Stock Offering Details
• BBOT Showcases Innovative Cancer Therapeutics at Key Conference
• Bombardier Global 8000: The New Era of Speed in Business Aviation
• James River Group's Upcoming Third Quarter Earnings Call Details
• Adeia Inc. Ready to Share Q3 2025 Financial Insights Soon
• iMDx Appoints Steven Tahmooressi as New Marketing VP
• Upcoming Earnings Call for The RealReal: What to Expect
• Insights into BBOT's Upcoming Presentations at AACR-NCI-EORTC
• PubMatic Inc. Investors: Important Class Action Update
• Discover the Latest Advancements from Zentalis Pharmaceuticals
• Unraveling the Mechanism of Action of MICVO in Cancer Therapy
• QuantumScape Stock Soars: New Opportunities in Battery Tech
• LifeVantage to Showcase Innovative Health Products at LD Micro Event
• EverQuote Set to Present Q3 2025 Financial Results Soon
• New Developments at Boundless Bio Spark Excitement in Oncology
• Investors Urged to Act Fast on Quantum Corporation Class Action
• Avadel Pharmaceuticals Reports Employee Stock Options Grant
• Hubbell Set to Reveal Q3 Financial Insights on October 28
• Investors Advised on Jasper Therapeutics Class Action Options